North America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 25 tables and 44 figures, this 107-page report "North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• HSV-1
• HSV-2
Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Acyclovir
• Valacyclovir
• Famciclovir
• Other Drugs
By Route of Administration, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Oral
• Topical
• Injection
By Patient Gender, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Female
• Male
By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Drug Stores
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of North America Market by Virus Type 40
3.1 Market Overview by Virus Type 40
3.2 HSV-1 42
3.3 HSV-2 43
4 Segmentation of North America Market by Drug Type 44
4.1 Market Overview by Drug Type 44
4.2 Acyclovir 47
4.3 Valacyclovir 48
4.4 Famciclovir 49
4.5 Other Drugs 50
5 Segmentation of North America Market by Route of Administration 52
5.1 Market Overview by Route of Administration 52
5.2 Oral 54
5.3 Topical 55
5.4 Injection 56
6 Segmentation of North America Market by Patient Gender 57
6.1 Market Overview by Patient Gender 57
6.2 Female 59
6.3 Male 60
7 Segmentation of North America Market by Distribution Channel 61
7.1 Market Overview by Distribution Channel 61
7.2 Retail Pharmacies 63
7.3 Hospital Pharmacies 64
7.4 Online Pharmacies 65
7.5 Drug Stores 66
8 North America Market 2022-2032 by Country 67
8.1 Overview of North America Market 67
8.2 U.S. 70
8.3 Canada 75
8.4 Mexico 77
9 Competitive Landscape 79
9.1 Overview of Key Vendors 79
9.2 New Product Launch, Partnership, Investment, and M&A 82
9.3 Company Profiles 83
Abbott 83
ADLEY FORMULATIONS 85
Aurobindo Pharma Ltd. 86
Avet Pharmaceuticals Inc. 87
Bausch Health Companies 88
Centurion Remedies 89
Cipla Ltd. 90
Eli Lilly & Company 91
Finecure Pharmaceuticals 92
GlaxoSmithKline Plc 93
Glenmark Pharmaceuticals 94
Macleods Pharmaceuticals 95
Medico Remedies 96
Merck & Co., Inc. 97
Novartis AG 98
Pfizer 99
Reddy's Laboratories 100
Sanofi SA 101
Teva Pharmaceutical Industries Ltd. 102
Torrent Pharma 103
Viatris Inc. 104
Zeelab Pharmacy 105
Zydus Pharmaceuticals, Inc. 106
RELATED REPORTS 107
The Treatment Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
Market Overview
The North America Vanadium Market is expected to experience substantial growth from 2024 to 2034, driven by increasing demand from various sectors such as iron and steel, energy storage, and chemicals. The market is projected to grow from USD XXX.XX million in 2024 to US...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The North America Anti-Pollution Mask Market is anticipated to witness significant growth from 2024 to 2034, driven by increasing awareness of air quality issues and the rising prevalence of respiratory diseases. The market, encompassing a wide range of anti-pollution ma...
Market Overview
The North America Ethnic Wear Market is set to experience considerable growth from 2024 to 2034, driven by evolving fashion trends and a growing appreciation for cultural heritage. The market, which includes a diverse range of ethnic apparel, is projected to reach USD XX...
Market Overview
The North America FinTech Investment Market is set to experience substantial growth from 2024 to 2034, driven by an accelerated adoption of innovative financial technologies across various sectors. The market, which encompasses investments in a wide range of FinTech solu...
Market Overview
The North America Airport Asset Tracking Market is set for significant growth from 2024 to 2034, driven by advancements in asset tracking technologies and increased focus on operational efficiency and safety within airport environments. The market is projected to grow fr...
Market Overview
The North America Sustainable Aviation Fuel Market is projected to experience robust growth from 2024 to 2034, driven by increasing environmental regulations, rising focus on reducing carbon emissions in aviation, and advancements in alternative fuel technologies. By 203...
The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...